and enables sophisticated search and analysis while maintaining full interoperability with existing regulatory systems and Unique Ingredient Identifiers (UNIIs). Autopoiesis Sciences, guided by Chief Scientist Larry Callahan's decade of leadership in substance registration at the Food and Drug Administration (FDA), has developed the Global Substance Knowledge System to evolve the successful Global Substance Registration System (GSRS) model created through partnerships with National Center for Advancing Translational Sciences (NCATS), regulatory agencies including European Medicines Agency (EMA), standards organizations like United States Pharmacopeia (USP) and Uppsala Monitoring Centre (UMC), Federal Institute for Drugs and Medical Devices (BfARM), and pharmaceutical companies coordinated through the Pistoia Alliance.